OAM
INDV icon

OP Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

OP Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Sell
97,446
-170,084
-64% -$6.17M 0.04% 308
2026
Q1 		$8.15M Buy
267,530
+190,684
+248% +$6.3M 0.08% 168
2025
Q4 		$2.76M Buy
+76,846
New +$2.35M 0.03% 360

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

OP Asset Management's INDV Position: Q2 2026 in Review

OP Asset Management reduced its Indivior Pharmaceuticals (INDV) stake by 64% in Q2 2026, selling an estimated $6.17M and leaving 97,446 shares worth $4M. The position accounts for 0.04% of the portfolio, ranked #308.

OP Asset Management first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.15M in Q1 2026. 59 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • OP Asset Management held 97,446 shares of Indivior Pharmaceuticals worth $4M as of Q2 2026.
  • OP Asset Management sold 170,084 Indivior Pharmaceuticals shares in Q2 2026, an estimated $6.17M.
  • Indivior Pharmaceuticals made up 0.04% of OP Asset Management's portfolio in Q2 2026, its #308 holding.
  • OP Asset Management first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • OP Asset Management's Indivior Pharmaceuticals position peaked at $8.15M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.